{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:06:57Z","timestamp":1780103217525,"version":"3.54.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytica Chimica Acta"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.aca.2026.345652","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:20:37Z","timestamp":1778628037000},"page":"345652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A dual green chromatographic platform for bioanalytical quantification and pharmacokinetic characterization of the BBD antineoplastic regimen"],"prefix":"10.1016","volume":"1411","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8379-6865","authenticated-orcid":false,"given":"Marco M.Z.","family":"Sharkawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha H.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norhan R.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loah R.","family":"Hemeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa S.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aca.2026.345652_bib1","first-page":"3","article-title":"Epidemiology, staging, and management of multiple myeloma","volume":"9","author":"Padala","year":"2021","journal-title":"Med. Sci."},{"key":"10.1016\/j.aca.2026.345652_bib2","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.3390\/jcm10235504","article-title":"Bendamustine-based regimens as salvage therapy in refractory\/relapsed multiple myeloma patients: a retrospective real-life analysis by the polish myeloma group","volume":"10","author":"Grzasko","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.aca.2026.345652_bib3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.beha.2007.09.003","article-title":"Bortezomib in multiple myeloma","volume":"20","author":"Mateos","year":"2007","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.aca.2026.345652_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/10428194.2022.2136950","article-title":"From mechanism to resistance\u2013changes in the use of dexamethasone in the treatment of multiple myeloma","volume":"64","author":"Rosenberg","year":"2023","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.aca.2026.345652_bib5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood.V120.21.943.943","article-title":"Treatment with bendamustine-bortezomib-dexamethasone (BBD) in relapsed\/refractory multiple myeloma shows significant activity and is well tolerated","volume":"120","author":"Ludwig","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.aca.2026.345652_bib6","series-title":"Bendamustine-Bortezomib-Dexamethasone in relapsed\/refractory Multiple Myeloma","author":"Cerchione","year":"2023"},{"key":"10.1016\/j.aca.2026.345652_bib7","doi-asserted-by":"crossref","DOI":"10.1188\/08.CJON.799-806","article-title":"Bendamustine: a novel cytotoxic agent for hematologic malignancies","volume":"12","author":"Blumel","year":"2008","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.aca.2026.345652_bib8","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa030288","article-title":"A phase 2 study of bortezomib in relapsed, refractory myeloma","volume":"348","author":"Richardson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.aca.2026.345652_bib9","first-page":"1681","article-title":"Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies","volume":"8","author":"Greenstein","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.aca.2026.345652_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10337-022-04232-1","article-title":"FDA-validated ecofriendly chromatographic methods for simultaneous determination of gemcitabine and sorafenib: applications to pharmacokinetics","volume":"86","author":"Sharkawi","year":"2023","journal-title":"Chromatographia"},{"key":"10.1016\/j.aca.2026.345652_bib11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1039\/D3AY00081H","article-title":"Ecofriendly LC-MS\/MS and TLC-densitometric methods for simultaneous quantitative assay and monitoring of BEGEV regimen, in vivo pharmacokinetic study application","volume":"15","author":"Sharkawi","year":"2023","journal-title":"Anal. Methods"},{"key":"10.1016\/j.aca.2026.345652_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-15078-6","article-title":"Novel environmental and sustainable approach for concurrent assay of antineoplastics in VMP regimen with a comprehensive pharmacokinetic study","volume":"15","author":"Mz Sharkawi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.aca.2026.345652_bib13","first-page":"133","article-title":"A validated RP-HPLC method for the determination of bendamustine hydrochloride in tablet dosage form using gemcitabine hydrochloride as internal standard","volume":"37","author":"Katare","year":"2012","journal-title":"Fabad J. Pharm. Sci."},{"key":"10.1016\/j.aca.2026.345652_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1055\/s-0043-108124","article-title":"Sensitive LC-MS\/MS method for the simultaneous determination of bendamustine and its active metabolite, \u03b3-hydroxybendamustine in small volume mice and dog plasma and its application to a pharmacokinetic study in mice and dogs","volume":"67","author":"Chandrashekar","year":"2017","journal-title":"Drug Research"},{"key":"10.1016\/j.aca.2026.345652_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jchromb.2012.02.039","article-title":"Development and validation of LC\u2013MS\/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine","volume":"893","author":"Dubbelman","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.aca.2026.345652_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.22270\/jddt.v13i6.5889","article-title":"Method development and validation for quantitative estimation of bortezomib in its bulk and pharmaceutical formulation","volume":"13","author":"Srikanth","year":"2023","journal-title":"J. Drug Deliv. Therapeut."},{"key":"10.1016\/j.aca.2026.345652_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7324\/JAPS.2017.70105","article-title":"A validated LC-MS\/MS method for the estimation of bortezomib and bortezomib D3 (IS) in human plasma with protein precipitation and SPE filter cartridges","volume":"7","author":"Chandramowli","year":"2017","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.aca.2026.345652_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122905","article-title":"A simplified method for bortezomib determination using dried blood spots in combination with liquid chromatography\/tandem mass spectrometry","volume":"1181","author":"Guo","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.aca.2026.345652_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.18196\/jfaps.v2i1.12450","article-title":"Qualitative and quantitative analysis of dexamethasone in rheumatic pain herbal medicine using thin-layer chromatography (TLC)\u2014Densitometry","volume":"2","author":"Permatasari","year":"2021","journal-title":"J. Fundam Appl. Pharm. Sci."},{"key":"10.1016\/j.aca.2026.345652_bib20","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1081\/JLC-200025726","article-title":"HPLC determination of dexamethasone in human plasma","volume":"27","author":"Song","year":"2004","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.aca.2026.345652_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.arabjc.2014.11.016","article-title":"Simultaneous determination of dexamethasone and moxifloxacin in pharmaceutical formulations using stability indicating HPLC method","volume":"10","author":"Razzaq","year":"2017","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.aca.2026.345652_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jchromb.2010.11.003","article-title":"Determination of dexamethasone and dexamethasone sodium phosphate in human plasma and cochlear perilymph by liquid chromatography\/tandem mass spectrometry","volume":"879","author":"Zhang","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.aca.2026.345652_bib23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/bmc.3316","article-title":"Development and validation of a highly sensitive LC\u2010MS\/MS method for the determination of dexamethasone in nude mice plasma and its application to a pharmacokinetic study","volume":"29","author":"Yuan","year":"2015","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.aca.2026.345652_bib24","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1039\/D3GC02347H","article-title":"Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality","volume":"25","author":"Manousi","year":"2023","journal-title":"Green Chem."},{"key":"10.1016\/j.aca.2026.345652_bib25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","article-title":"A new tool for the evaluation of the analytical procedure: green analytical procedure index","volume":"181","author":"P\u0142otka-Wasylka","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.aca.2026.345652_bib26","series-title":"13th Green Chem Conf., USA","article-title":"Green assessment of chemical methods","author":"Raynie","year":"2009"},{"key":"10.1016\/j.aca.2026.345652_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2022.116553","article-title":"AGREEprep\u2013analytical greenness metric for sample preparation","volume":"149","author":"Wojnowski","year":"2022","journal-title":"TrAC, Trends Anal. Chem."},{"key":"10.1016\/j.aca.2026.345652_bib28","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Janet","year":"2011"},{"key":"10.1016\/j.aca.2026.345652_bib29","series-title":"Bioanalytical Method Validation Guidance for Industry","year":"2013"}],"container-title":["Analytica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267026006021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267026006021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:38:36Z","timestamp":1780101516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267026006021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"alternative-id":["S0003267026006021"],"URL":"https:\/\/doi.org\/10.1016\/j.aca.2026.345652","relation":{},"ISSN":["0003-2670"],"issn-type":[{"value":"0003-2670","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A dual green chromatographic platform for bioanalytical quantification and pharmacokinetic characterization of the BBD antineoplastic regimen","name":"articletitle","label":"Article Title"},{"value":"Analytica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aca.2026.345652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"345652"}}